# Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa

> **NCT05285917** · PHASE3 · RECRUITING · sponsor: **Brown University** · enrollment: 400 (estimated)

## Conditions studied

- Sickle Cell Anemia in Children
- Sickle Cell Disease

## Interventions

- **DRUG:** Hydroxyurea

## Key facts

- **NCT ID:** NCT05285917
- **Lead sponsor:** Brown University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-15
- **Primary completion:** 2026-09-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-04-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05285917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05285917, "Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05285917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*